Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carmen Ibáñez-Villoslada"'
Autor:
Marta Dominguez Morcillo, Carmen Ibáñez Villoslada, Joaquín Navarro Castellón, Paula Sáez Bueno, Eliseo Carrasco Esteban, Andrea Matas Escamillas, Zigor Zalabarría Zarrabeitia, María Concepción López Carrizosa
Publikováno v:
Journal of Oncology Research. 4
Low dose rate brachytherapy (LDR) is an accepted, effective treatment with few local side effects, used as monotherapy in patients with low-risk prostate cancer (PC). The aim of this paper is to analyse 245 patients treated with LDR in the Radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56bbd1a5334b45d2b2c409e747b23429
https://doi.org/10.30564/jor.v4i2.4721
https://doi.org/10.30564/jor.v4i2.4721
Autor:
G. Sancho, Juana Tripero, Eva Maria Lozano Martin, Laura Guzmán Gómez, Carmen Ibáñez Villoslada, Mónica Ramos Albiac, Begoña Caballero, Mikel Rico Rico Oses, Marcos Guijarro Verdú, Amadeo Wals, Silvia Rodríguez Villalba, Ana María Soler Soler Rodríguez, José Zapatero Ortuño, Beatriz Álvarez, Jesús Fernández López, Pilar Samper Ots, Patricia Diezhandino Garcia, Sara Pedraza Fernández, Esther Mayrata Canellas, Moisés Mira Flores, V. Macias, Maider Campo Vargas, Claudio Fuentes Sánchez, Adriana Fondevilla Soler, Carmen González San Segundo, M. Chust, J.M. Solé, Laura Torrado Moya, Gonzalo Vázquez Masedo, José Expósito Hernández, Teresa Muñoz Miguelañez
Publikováno v:
RADIOTHERAPY AND ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Radiotherapy And Oncology
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Radiotherapy And Oncology
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4b0d2117564ec6149020f159ad4701
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4462
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4462
Autor:
Carmen Ibáñez-Villoslada, Francisco Clemente-Gutiérrez, Consuelo Pérez-Vara, José Pérez-Regadera, María H. Clavo-Herranz, Concepción López-Carrizosa
Publikováno v:
Journal of Applied Clinical Medical Physics
VMAT is a powerful technique to deliver hypofractionated prostate treatments. The lack of correlations between usual 2D pretreatment QA results and the clinical impact of possible mistakes has allowed the development of 3D verification systems. Dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754ed86f040865c3b034042d95d0cf30
https://doi.org/10.1120/jacmp.v17i2.5783
https://doi.org/10.1120/jacmp.v17i2.5783
Autor:
Maria Victoria De Torres, Olombrada, Ana Alvarez, González, Carmen Ibáñez, Villoslada, Begoña Caballero, Perea, Blanca Ludeña, Martinez, Pastora Caballero, Guerra
Publikováno v:
Archivos espanoles de urologia. 65(1)
Adjuvant radiotherapy (RT) has proven to be more effective in patients at high risk of relapse than salvage RT when this relapse occurs. To optimize its use we must identify the subset of patients at greater risk of residual microscopic disease after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c10030ee2aa712feb281ebb852987fa
https://pubmed.ncbi.nlm.nih.gov/22322647
https://pubmed.ncbi.nlm.nih.gov/22322647
Publikováno v:
Archivos espanoles de urologia. 65(1)
Prostate specific antigen (PSA) is the main tool in the follow-up of prostate cancer patients after definitive therapy. It's widely used as an early marker to value treatment success. Biochemical recurrence predicts metastatic disease progression and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9806eaf65335bdb93177e62be79d7e44
https://pubmed.ncbi.nlm.nih.gov/22318174
https://pubmed.ncbi.nlm.nih.gov/22318174
Autor:
Ma Victoria, de Torres Olombrada, Carmen, González San Segundo, Juan A, Santos Miranda, Carmen, Ibáñez Villoslada, Juan I, Martínez Salamanca, Felipe, Herranz Amo, Felipe A, Calvo Manuel
Publikováno v:
Archivos espanoles de urologia. 60(6)
Recently it has been reported in the EORTC (European Organisation for Research and Treatment of Cancer) trial 22911 and the SWOG (Southwest Oncology Group) 8794, the evidence that radiotherapy (RT) is an effective treatment after the prostatectomy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b4491abff2ff01d23c03313904bf118
https://pubmed.ncbi.nlm.nih.gov/17847737
https://pubmed.ncbi.nlm.nih.gov/17847737
Autor:
Carmen González San Segundo, Mª Victoria de Torres Olombrada, Juan Ignacio Martínez Salamanca, Juan Antonio Santos Miranda, Felipe A. Calvo Manuel, Felipe Herranz Amo, Carmen Ibáñez Villoslada
Publikováno v:
Archivos Españoles de Urología (Ed. impresa) v.60 n.6 2007
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Objetivo: Recientemente se han comunicado firmes evidencias por la EORTC (European Organisation for Research and Treatment of Cancer - ensayo 22911) y el SWOG (Southwest Oncology Group - ensayo 8794), señalando que la radioterapia (RT) es un tratami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7120cb004eff5930d9b28e28d559ed8e
https://doi.org/10.4321/s0004-06142007000600004
https://doi.org/10.4321/s0004-06142007000600004